What is HC Wainwright's updated price target and rating for Calumet Specialty Products Partners, and what implied upside does it represent?

HC Wainwright raised its price target for Calumet (NASDAQ: CLMT) from $60 to $75 and maintained a 'buy' rating, indicating a 45.57% upside potential based on the new target.

How did Calumet's latest financial performance compare year-over-year in terms of revenue, and how did it fare against earnings expectations?

Calumet reported a 40.8% year-over-year revenue increase to $1.45 billion, but missed earnings expectations with a loss of $1.09 per share.

HC Wainwright Raises Calumet Price Target to $75, Maintains Buy Rating

Sep 2, 2026

HC Wainwright raised its price target for Calumet Specialty Products Partners to $75, citing a 40.8% year-over-year revenue increase. Despite missing earnings expectations, the firm maintains a buy rating with significant upside potential.

MarketBeat

2026-03-30

Adams Asset Advisors LLC Holds $102.46M Stake in Calumet, Inc.

2026-03-30

Calumet (NASDAQ:CLMT) Given New $60.00 Price Target at HC Wainwright

2026-03-31

H.C. Wainwright Raises Calumet Stock Price Target to $60 from $33

2026-04-02

Calumet (NASDAQ:CLMT) Director Daniel Sajkowski Sells 3,310 Shares

2026-04-05

Calumet, Inc. Receives Consensus 'Hold' Rating from Brokerages